| Company Name: |
Zhengzhou Granlen Sciences, ltd.
|
| Tel: |
0371-85513397 +86-18610099868 |
| Email: |
info@granlen.com |
| Products Intro: |
Product Name:4-Amino-5-cyano-1-(β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine
CAS:1704-25-2
Purity: 95% HPLC Package:根据客户需要包装 Remarks:GL101581
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:4-Amino-5-cyano-1-(β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] ? pyrimidine
CAS:1704-25-2
Package:5mg;10mg;25mg
|
1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-1-β-D-ribofuranosyl- manufacturers
|
| | 1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-1-β-D-ribofuranosyl- Basic information |
| Product Name: | 1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-1-β-D-ribofuranosyl- | | Synonyms: | 1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-1-β-D-ribofuranosyl-;4-Amino-5-cyano-1-(β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine;4-Amino-5-cyano-1-(β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine;4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile | | CAS: | 1704-25-2 | | MF: | C12H13N5O4 | | MW: | 291.27 | | EINECS: | | | Product Categories: | | | Mol File: | 1704-25-2.mol | ![1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-1-β-D-ribofuranosyl- Structure](CAS/20211123/GIF/1704-25-2.gif) |
| | 1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-1-β-D-ribofuranosyl- Chemical Properties |
| Melting point | 244.0-245.5 °C | | Boiling point | 521.4±60.0 °C(Predicted) | | density | 1.91±0.1 g/cm3(Predicted) | | pka | 12.95±0.70(Predicted) |
| | 1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-1-β-D-ribofuranosyl- Usage And Synthesis |
| Uses | 4-Amino-5-cyano-1- (β-D-ribofuranosyl)-7H-pyrrolo[2,3-d] pyrimidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-1-β-D-ribofuranosyl- Preparation Products And Raw materials |
|